company

POLAR BIOMEDICALS AS

8007 BODØ

Return on Equity
12,57 %
Current Ratio
2,63
Debt-to-Equity Ratio
0
Key figures (NOK)2022
Revenue22 857 000
Net Income956 000
Total Assets12 280 000
Total Equity7 605 000
Income (NOK)2022
Revenue22 857 000
Expenditure22 850 000
Operating Profit1 376 000
Financial Income138 000
Financial Costs278 000
Financial Balance−140 000
Earnings Before Tax1 236 000
Tax280 000
Net Income956 000
Balance (NOK)2022
Total Fixed Assets6 000
Total Current Assets12 275 000
Total Assets12 280 000
Total Retained Equity6 278 000
Total Equity7 605 000
Total Long-Term Debt0
Total Current Debt4 675 000
Total Equity and Debt12 280 000
Cash flow (NOK)2022
Sales Income22 917 000
Other Income−60 000
Revenue22 857 000
Cost of Goods Sold17 260 000
Salary Costs1 569 000
Depreciation6 000
Impairment0
Expenditure22 850 000
Operating Profit1 376 000
Financial Income138 000
Financial Costs278 000
Financial Balance−140 000
Dividends0
Net Income956 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures6 000
Total Tangible Assets6 000
Total Fiancial Fixed Assets0
Total Fixed Assets6 000
Stock5 986 000
Total Investments0
Cash, Bank3 494 000
Total Current Assets12 275 000
Total Assets12 280 000
Total Equity7 605 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors3 226 000
Unpaid Taxes1 020 000
Dividends0
Other Current Debt150 000
Total Current Debt4 675 000
Total Equity and Debt12 280 000
Financial indicators2022
Return on Equity12,57 %
Debt-to-Equity Ratio0
Operating Profit Margin6,02 %
Current Ratio2,63
Quick Ratio−9,36
Equity Ratio0,62
Gross Profit Margin24,49 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English